These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1272 related articles for article (PubMed ID: 19074831)
21. Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts. Cappellini A; Mantovani I; Tazzari PL; Grafone T; Martinelli G; Cocco L; Martelli AM Int J Mol Med; 2005 Dec; 16(6):1041-8. PubMed ID: 16273284 [TBL] [Abstract][Full Text] [Related]
22. Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells. Nakata S; Yoshida T; Horinaka M; Shiraishi T; Wakada M; Sakai T Oncogene; 2004 Aug; 23(37):6261-71. PubMed ID: 15208660 [TBL] [Abstract][Full Text] [Related]
24. Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. Hetschko H; Voss V; Seifert V; Prehn JH; Kögel D FEBS J; 2008 Apr; 275(8):1925-36. PubMed ID: 18341587 [TBL] [Abstract][Full Text] [Related]
25. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response. Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157 [TBL] [Abstract][Full Text] [Related]
26. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154 [TBL] [Abstract][Full Text] [Related]
27. Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors. Wenger T; Mattern J; Penzel R; Gassler N; Haas TL; Sprick MR; Walczak H; Krammer PH; Debatin KM; Herr I Cell Death Differ; 2006 Oct; 13(10):1740-51. PubMed ID: 16470224 [TBL] [Abstract][Full Text] [Related]
28. Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor. van der Sloot AM; Tur V; Szegezdi E; Mullally MM; Cool RH; Samali A; Serrano L; Quax WJ Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8634-9. PubMed ID: 16731632 [TBL] [Abstract][Full Text] [Related]
29. Over-expression of Reticulon 3 (RTN3) enhances TRAIL-mediated apoptosis via up-regulation of death receptor 5 (DR5) and down-regulation of c-FLIP. Lee JT; Lee TJ; Kim CH; Kim NS; Kwon TK Cancer Lett; 2009 Jul; 279(2):185-92. PubMed ID: 19250737 [TBL] [Abstract][Full Text] [Related]
30. Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis. Ohtsuki T; Kikuchi H; Koyano T; Kowithayakorn T; Sakai T; Ishibashi M Bioorg Med Chem; 2009 Sep; 17(18):6748-54. PubMed ID: 19682913 [TBL] [Abstract][Full Text] [Related]
31. Lupulone, a hop bitter acid, activates different death pathways involving apoptotic TRAIL-receptors, in human colon tumor cells and in their derived metastatic cells. Lamy V; Roussi S; Chaabi M; Gossé F; Lobstein A; Raul F Apoptosis; 2008 Oct; 13(10):1232-42. PubMed ID: 18726190 [TBL] [Abstract][Full Text] [Related]
32. Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells. Hori T; Kondo T; Kanamori M; Tabuchi Y; Ogawa R; Zhao QL; Ahmed K; Yasuda T; Seki S; Suzuki K; Kimura T J Orthop Res; 2010 Jun; 28(6):739-45. PubMed ID: 20041491 [TBL] [Abstract][Full Text] [Related]
33. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158 [TBL] [Abstract][Full Text] [Related]
34. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing. Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796 [TBL] [Abstract][Full Text] [Related]
35. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688 [TBL] [Abstract][Full Text] [Related]
36. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5. Horak P; Pils D; Kaider A; Pinter A; Elandt K; Sax C; Zielinski CC; Horvat R; Zeillinger R; Reinthaller A; Krainer M Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8585-91. PubMed ID: 16361541 [TBL] [Abstract][Full Text] [Related]
37. Hydrogen peroxide enhances TRAIL-induced cell death through up-regulation of DR5 in human astrocytic cells. Kwon D; Choi K; Choi C; Benveniste EN Biochem Biophys Res Commun; 2008 Aug; 372(4):870-4. PubMed ID: 18534188 [TBL] [Abstract][Full Text] [Related]
38. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death. Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836 [TBL] [Abstract][Full Text] [Related]
39. Enhancement of antitumor properties of rhTRAIL by affinity increase toward its death receptors. Reis CR; van der Sloot AM; Szegezdi E; Natoni A; Tur V; Cool RH; Samali A; Serrano L; Quax WJ Biochemistry; 2009 Mar; 48(10):2180-91. PubMed ID: 19236007 [TBL] [Abstract][Full Text] [Related]
40. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma. Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]